Want to see IN:VENUSREM full AI Analyst Report?
Venus Remedies Limited (VENUSREM) Stock Statistics & Valuation Metrics
Total Valuation
Venus Remedies Limited has a market cap or net worth of INR 16.46B. The enterprise value is INR 23.23B.
- Market Cap
- INR 16.46B
- Enterprise Value
- INR 23.23B
Share Statistics
Venus Remedies Limited has 13,366,988 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,366,988
- Owned by Insiders
- ―
- Owned by Institutions
- 0.36%
Financial Efficiency
Venus Remedies Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 13.44%.
- Return on Equity (ROE)
- 0.15
- Return on Assets (ROA)
- 0.12
- Return on Invested Capital (ROIC)
- 13.44%
- Return on Capital Employed (ROCE)
- 0.18
- Revenue Per Employee
- 5.23M
- Profits Per Employee
- 698.23K
- Employee Count
- 1,472
- Asset Turnover
- 0.90
- Inventory Turnover
- 3.88
Valuation Ratios
The current PE Ratio of Venus Remedies Limited is 13.61. Venus Remedies Limited’s PEG ratio is 0.19.
- PE Ratio
- 13.61
- PS Ratio
- 1.98
- PB Ratio
- 2.35
- Price to FCF
- 24.27
- Price to Operating Cash Flow
- 20.41
- PEG Ratio
- 0.19
Income Statement
In the last 12 months, Venus Remedies Limited had revenue of 7.70B and earned 1.03B in profits. Earnings per share was 76.89.
- Revenue
- 7.70B
- Gross Profit
- 2.68B
- Operating Income
- 1.22B
- Pretax Income
- 1.34B
- Net Income
- 1.03B
- EBITDA
- 1.60B
- Earnings Per Share (EPS)
- 76.89
Cash Flow
In the last 12 months, operating cash flow was 811.10M and capital expenditures -128.90M, giving a free cash flow of 682.20M billion.
- Operating Cash Flow
- 811.10M
- Free Cash Flow
- 682.20M
- Free Cash Flow per Share
- 51.04
Dividends & Yields
Venus Remedies Limited pays an annual dividend of INR 10.00, resulting in a dividend yield of 0.82%
- Dividend Per Share
- INR 10.00
- Dividend Yield
- 0.82%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.12%
- Earnings Yield
- 7.35%
Stock Price Statistics
- Beta
- 0.73
- 52-Week Price Change
- 181.32%
- 50-Day Moving Average
- 1613.79
- 200-Day Moving Average
- 1303.40
- Relative Strength Index (RSI)
- 26.52
- Average Volume (3m)
- 3,800
Important Dates
Venus Remedies Limited upcoming earnings date is Feb 14, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 26, 2026
- Next Earnings Date
- Feb 14, 2027
- Ex-Dividend Date
- Aug 07, 2026
Financial Position
Venus Remedies Limited as a current ratio of 2.44, with Debt / Equity ratio of 1.87%
- Current Ratio
- 2.44
- Quick Ratio
- 1.64
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.11
- Interest Coverage Ratio
- 3040.25
Taxes
In the past 12 months, Venus Remedies Limited has paid 313.70M in taxes.
- Income Tax
- 313.70M
- Effective Tax Rate
- 0.23
Enterprise Valuation
Venus Remedies Limited EV to EBITDA ratio is 8.91, with an EV/FCF ratio of 24.18.
- EV to Sales
- 1.97
- EV to EBITDA
- 8.91
- EV to Free Cash Flow
- 24.18
- EV to Operating Cash Flow
- 20.33
Balance Sheet
Venus Remedies Limited has INR 1.03B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 1.03B billion.
- Cash & Marketable Securities
- INR 1.03B
- Total Debt
- INR 0.00
- Net Cash
- INR 1.03B
- Net Cash Per Share
- INR 77.36
- Tangible Book Value Per Share
- INR 496.56
Margins
Gross margin is 37.74%, with operating margin of 17.68%, and net profit margin of 14.53%.
- Gross Margin
- 37.74%
- Operating Margin
- 17.68%
- Pretax Margin
- 18.94%
- Net Profit Margin
- 14.53%
- EBITDA Margin
- 22.11%
- EBIT Margin
- 18.57%
Analyst Forecast
The average price target for Venus Remedies Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 20.22%
- EPS Growth Forecast
- 73.03%
Scores
- Smart Score
- ―
- AI Score
- 74